Deutsche Bank’s Checkpoint Therapeutics CKPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-80
Closed -$2K 4204
2021
Q4
$2K Sell
80
-6,515
-99% -$216K ﹤0.01% 4218
2021
Q3
$218K Sell
6,595
-202
-3% -$5.97K ﹤0.01% 3523
2021
Q2
$200K Sell
6,797
-37,867
-85% -$1.05M ﹤0.01% 3790
2021
Q1
$1.4M Buy
44,664
+40,692
+1,024% +$1.36M ﹤0.01% 2443
2020
Q4
$105K Buy
3,972
+1,371
+53% +$34.7K ﹤0.01% 3819
2020
Q3
$70K Buy
2,601
+594
+30% +$14.3K ﹤0.01% 3716
2020
Q2
$40K Buy
2,007
+844
+73% +$15.4K ﹤0.01% 3905
2020
Q1
$18K Buy
1,163
+300
+35% +$5.31K ﹤0.01% 3933
2019
Q4
$14K Buy
863
+169
+24% +$2.83K ﹤0.01% 4397
2019
Q3
$16K Sell
694
-3,298
-83% -$90.5K ﹤0.01% 4392
2019
Q2
$120K Buy
+3,992
New +$157K ﹤0.01% 4114
2018
Q4
Sell
-197
Closed -$7K 5178
2018
Q3
$7K Buy
+197
New +$6.88K ﹤0.01% 5141

Other funds holding CKPT

Deutsche Bank's CKPT Position: Q1 2022 in Review

Deutsche Bank sold out of Checkpoint Therapeutics (CKPT) in Q1 2022, closing a stake of 80 shares — an estimated $2K sold.

Deutsche Bank first reported a position in CKPT in Q3 2018 and held it in 12 quarters. The position peaked at $1.4M in Q1 2021. 67 funds tracked by Wall St. Rank hold CKPT as of Q1 2022.

  • Deutsche Bank reported no remaining Checkpoint Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Deutsche Bank sold 80 Checkpoint Therapeutics shares in Q1 2022, an estimated $2K.
  • Deutsche Bank first reported a position in Checkpoint Therapeutics in Q3 2018 and held it in 12 quarters.
  • Deutsche Bank's Checkpoint Therapeutics position peaked at $1.4M in Q1 2021.
  • 67 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2022.

Based on Deutsche Bank's 13F filing for Q1 2022, filed 13 May 2022.